Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,951 | -30,369 | -221,247 | -200,099 | -170,126 |
| Depreciation Amortization | 1,980 | 954 | 3,647 | 2,710 | 1,779 |
| Accounts receivable | -19,293 | -2,596 | -39,331 | -16,992 | -12,458 |
| Other Working Capital | 4,178 | 1,545 | -12,376 | -16,422 | -14,865 |
| Other Operating Activity | 43,509 | 14,819 | 102,532 | 69,029 | 48,011 |
| Operating Cash Flow | $-17,577 | $-15,647 | $-166,775 | $-161,774 | $-147,659 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -105 | -61 | -229 | -142 | -115 |
| Investing Cash Flow | $-105 | $-61 | $-229 | $-142 | $-115 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 173,250 | 173,250 | N/A | N/A | N/A |
| Debt Repayment | -229,047 | -229,047 | N/A | N/A | N/A |
| Common Stock Issued | 126,116 | 591 | 1,638 | 373 | 80 |
| Common Stock Repurchased | N/A | N/A | -1,926 | -564 | N/A |
| Other Financing Activity | -128 | 121,846 | 0 | 0 | 0 |
| Financing Cash Flow | $70,191 | $66,640 | $-288 | $-191 | $80 |
| Beginning Cash Position | 132,833 | 132,833 | 300,125 | 300,125 | 300,125 |
| End Cash Position | 185,342 | 183,765 | 132,833 | 138,018 | 152,431 |
| Net Cash Flow | $52,509 | $50,932 | $-167,292 | $-162,107 | $-147,694 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,577 | -15,647 | -166,775 | -161,774 | -147,659 |
| Capital Expenditure | -105 | -61 | -229 | -142 | -115 |
| Free Cash Flow | -17,682 | -15,708 | -167,004 | -161,916 | -147,774 |